Michael del Prado

Non-Executive Director / Cochlear

Michael del Prado has had an executive career of more than 30 years in the medical device and pharmaceutical industries, with senior leadership roles in Johnson and Johnson medical device businesses across the globe including the United States, Europe, the Middle East & Africa, and Asia Pacific.

For six years, Mr del Prado was group chair of Ethicon where he had overall responsibility for the business across the globe, driving its strategic, innovation, and commercialisation agenda and delivering on financial results worldwide. He also led J&J's Global Public Health efforts to enhance access to essential surgery.

Mr del Prado is a non-executive director of Cochlear and Ambu A/S, a medical device company listed on the NASDAQ OMX Copenhagen.

Lists and Charts

Roles

2022

Non-Executive Director

Cochlear

Year started and most recent title

Total Shareholder Return as at 02/12/24

Rank	Company	1 Yr	5 Yr
641^st	WT Financial Group	13.1%	13.69%
642^nd	Urbanise	13.1%	-10.09%
643^rd	Cochlear	12.92%	6.69%
644^th	De Grey Mining	12.76%	101.61%
645^th	New Talisman Gold Mines	12.74%	-23.41%

View Full List

1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

Person Activity

NEW ROLE: Non-Executive Director, Cochlear

25 Jan 2022

Related Information

Access to our data for Michael del Prado is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Michael del Prado is linked to 1 organisation which is included in 1 list - Public Companies - non WA.

To see the data you will need to Subscribe.